New UPS facility will boast nearly 6,000 square metres of healthcare-dedicated space to connect Ireland’s growing pharmaceutical and medtech industries to UPS’s global network.
UPS is to create 30 new jobs at its new UPS Healthcare facility which will connect Ireland’s healthcare and pharma industries to its global logistics network that serves customers in 220 countries.
The Dublin facility will support Ireland’s pharmaceutical and medical device industries in delivering next generation biologics, critical vaccines and vital healthcare equipment to patients around the world.
“This is a significant investment by UPS in Ireland and a demonstration of our commitment to enabling truly global healthcare supply chains”
The facility will create 30 jobs initially, and the investment demonstrates UPS commitment to the Irish market and support for its long-term export growth.
A chemical connection
80% of pharmaceutical drugs in the European Union require cold-chain logistical support and temperature-controlled transportation. More than 50% of all new drugs in the global pharmaceutical pipeline are cutting edge biomedical drugs – such as vaccines – that tend to be temperature-sensitive.
“This is a significant investment by UPS in Ireland and a demonstration of our commitment to enabling truly global healthcare supply chains,” said Cathy O’Brien, UPS Healtchare vice-president for International Sales.
“Our new facility supports the quality and regulatory needs of manufacturers, many of whom are providing critical upstream activity, and we provide them with resiliency and scale. UPS Healthcare is now offering the first truly dedicated freight, small parcel and logistics offering in Ireland, including cold chain management services. Ireland is a world leader in research, biologics and healthcare innovation, and we are confident that our clinical to commercial service offering will drive value for the Irish healthcare and economic ecosystem in the years to come.”
UPS recently announced its planned acquisition of the Bomi Group, which has temperature-controlled facilities in 14 countries in Europe and Latin America and will add nearly 3,000 highly skilled Bomi team members. With the approved completion of this acquisition by 2023, UPS Healthcare will have more than doubled the footprint of its facilities since 2020.
“This is a welcome development from UPS which will support the thriving, export led life science sector here which supplies lifesaving medicines to patients all over the world,” said Martin Shanahan, CEO of IDA Ireland.
